Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01929785 · ClinicalTrials.gov registry record
BIIR Gene to Manage Heart Allograft Patients
A clinical trial of Cardiac Transplant Failure, sponsored by Baylor Research Institute.
- Completed
- Registry status
- 56
- Enrollment target
- 1
- Study location
NCT01929785 is a study of Cardiac Transplant Failure that has completed, run by Baylor Research Institute. The registered enrollment target is 56 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01929785, a study of Cardiac Transplant Failure, has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- 56 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single center observational study. Duration of the study is 1 year. Participants will be followed in 2 groups. Group 1 will include all patients who have undergone a heart transplant, through the first year post transplant. Group 2 will include heart transplant recipients from 1 year to 2 years post transplant. Groups will be enrolled simultaneously. It is anticipated each group will have 25 participants.
Conditions Studied
Study Locations (1)
Texas
- Baylor University Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2009-12 |
| Est. Completion | 2013-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01929785
The ClinicalTrials.gov registry entry for NCT01929785 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cardiac Transplant Failure appearing as the primary indexed condition, and to 0 interventions.
NCT01929785 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01929785 about?
NCT01929785 is a clinical study titled "BIIR Gene to Manage Heart Allograft Patients". This is a single center observational study. Duration of the study is 1 year. Participants will be followed in 2 groups. Group 1 will include all patients who have undergone a heart transplant, through the first year post transplant. Group 2 will include heart transplant recipients from 1 year to 2 ...
What is the current status of trial NCT01929785?
This trial is currently completed. The enrollment target is 56 participants. The study started on 2009-12. Estimated completion is 2013-11.
What conditions does trial NCT01929785 study?
This clinical trial studies the following conditions: Cardiac Transplant Failure.
Who is sponsoring clinical trial NCT01929785?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01929785 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.